Armor Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $536K | Hold |
8,547
| – | – | 0.19% | 66 |
|
|
2025
Q4 | $815K | Hold |
8,547
| – | – | 0.3% | 55 |
|
|
2025
Q3 | $834K | Hold |
8,547
| – | – | 0.26% | 56 |
|
|
2025
Q2 | $918K | Hold |
8,547
| – | – | 0.35% | 50 |
|
|
2025
Q1 | $862K | Hold |
8,547
| – | – | 0.36% | 49 |
|
|
2024
Q4 | $763K | Hold |
8,547
| – | – | 0.31% | 54 |
|
|
2024
Q3 | $716K | Hold |
8,547
| – | – | 0.3% | 58 |
|
|
2024
Q2 | $658K | Hold |
8,547
| – | – | 0.3% | 60 |
|
|
2024
Q1 | $585K | Hold |
8,547
| – | – | 0.28% | 68 |
|
|
2023
Q4 | $494K | Buy |
8,547
+35
| +0.4% | +$1.87K | 0.26% | 72 |
|
|
2023
Q3 | $449K | Hold |
8,512
| – | – | 0.27% | 72 |
|
|
2023
Q2 | $460K | Buy |
8,512
+15
| +0.2% | +$783 | 0.28% | 72 |
|
|
2023
Q1 | $425K | Hold |
8,497
| – | – | 0.24% | 78 |
|
|
2022
Q4 | $393K | Hold |
8,497
| – | – | 0.24% | 84 |
|
|
2022
Q3 | $329K | Hold |
8,497
| – | – | 0.22% | 90 |
|
|
2022
Q2 | $317K | Hold |
8,497
| – | – | 0.21% | 89 |
|
|
2022
Q1 | $376K | Hold |
8,497
| – | – | 0.21% | 89 |
|
|
2021
Q4 | $361K | Hold |
8,497
| – | – | 0.2% | 93 |
|
|
2021
Q3 | $369K | Hold |
8,497
| – | – | 0.23% | 90 |
|
|
2021
Q2 | $363K | Hold |
8,497
| – | – | 0.22% | 92 |
|
|
2021
Q1 | $328K | Hold |
8,497
| – | – | 0.21% | 89 |
|
|
2020
Q4 | $305K | Buy |
+8,497
| New | +$306K | 0.22% | 85 |
|
|
2020
Q3 | – | Sell |
-9,497
| Closed | -$333K | – | 138 |
|
|
2020
Q2 | $333K | Hold |
9,497
| – | – | 0.29% | 74 |
|
|
2020
Q1 | $310K | Hold |
9,497
| – | – | 0.32% | 66 |
|
|
2019
Q4 | $429K | Hold |
9,497
| – | – | 0.33% | 70 |
|
|
2019
Q3 | $386K | Hold |
9,497
| – | – | 0.32% | 70 |
|
|
2019
Q2 | $408K | Hold |
9,497
| – | – | 0.34% | 69 |
|
|
2019
Q1 | $364K | Hold |
9,497
| – | – | 0.32% | 70 |
|
|
2018
Q4 | $336K | Hold |
9,497
| – | – | 0.34% | 70 |
|
|
2018
Q3 | $366K | Hold |
9,497
| – | – | 0.33% | 70 |
|
|
2018
Q2 | $311K | Sell |
9,497
-2,000
| -17% | -$60.3K | 0.28% | 81 |
|
|
2018
Q1 | $314K | Hold |
11,497
| – | – | 0.29% | 73 |
|
|
2017
Q4 | $285K | Hold |
11,497
| – | – | 0.26% | 79 |
|
|
2017
Q3 | $335K | Hold |
11,497
| – | – | 0.32% | 72 |
|
|
2017
Q2 | $319K | Hold |
11,497
| – | – | 0.32% | 74 |
|
|
2017
Q1 | $286K | Sell |
11,497
-1,000
| -8% | -$24.3K | 0.29% | 80 |
|
|
2016
Q4 | $270K | Buy |
+12,497
| New | +$273K | 0.28% | 79 |
|
Other funds holding BSX
VCM
VPM
Armor Investment Advisors's BSX Position: Q1 2026 in Review
Armor Investment Advisors held its Boston Scientific (BSX) position steady in Q1 2026 at 8,547 shares worth $536K. The position accounts for 0.19% of the portfolio, ranked #66.
Armor Investment Advisors first reported a position in BSX in Q4 2016 and has held it in 37 quarters since. The position peaked at $918K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Armor Investment Advisors held 8,547 shares of Boston Scientific worth $536K as of Q1 2026.
- Armor Investment Advisors left its Boston Scientific share count unchanged in Q1 2026.
- Boston Scientific made up 0.19% of Armor Investment Advisors's portfolio in Q1 2026, its #66 holding.
- Armor Investment Advisors first reported a position in Boston Scientific in Q4 2016 and has held it in 37 quarters since.
- Armor Investment Advisors's Boston Scientific position peaked at $918K in Q2 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Armor Investment Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.